Displaying drugs 14426 - 14450 of 14693 in total
2,3-Dimethyl-1,4-naphthoquinone
Experimental
Acetyl chloride
Experimental
Dihydroquinidine barbiturate
Experimental
Lawsone
Experimental
Mebicar
Experimental
1-Amino-1-Carbonyl Pentane
Experimental
Acetophenone
Experimental
ALKS 27
ALKS 27 is an inhaled formulation of trospium chloride for the treatment of chronic obstructive pulmonary disease (COPD). Study showed that ALKS 27 was well-tolerated over a wide dose range, with no dose-limited effects observed.
Investigational
Ezurpimtrostat
Investigational
RG-7795
Investigational
Plinabulin
Investigational
Flaviolin
Experimental
Bioymifi
Bioymifi is a small molecule that acts as a tumor necrosis factor-related apoptosis-induced ligand (TRAIL) mimetic. Upon binding to the death receptor 5 (DR5) on cancer cells, bioymifi triggers apoptosis, possibly through a caspase-dependent pathway. Bioymifi is currently being investigated as an anti-tumor agent.[A257048,A257053]
Investigational
CHGN111
CHGN111 is an inhibitor of the mitochondrial enzyme CLK-1 which is a demethoxyubiquinone hydroxylase. Numerous parameters of mitochondrial function are altered when the activity of CLK-1 is reduced, which results in a decrease of ROS at critical cellular sites, as well as in a decrease of systemic oxidative stress. It...
Investigational
Isopentyl Pyrophosphate
Experimental
Pentyl Trihydrogen Diphosphate
Experimental
1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE
Experimental
8-azaxanthine
Experimental
Displaying drugs 14426 - 14450 of 14693 in total